Loading companies…
ET
Elysium Therapeutics
United States · Biotech · Healthtech
Develops treatments to prevent and reverse overdoses caused by synthetic opioids
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| SAFE | $7.5M | Participants not disclosed |
Investors
No participants disclosed.
Coverage
Jan 28, 2026Elysium Therapeutics · SAFESimilar companies
GMGeneral MedicineAn online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.$120M · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
AventixAventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results.€1.2M · Pre-seed